New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena

Updated on: December 28,2023

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena

Updated on:December 28,2023

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du

Updated on: January 07,2024

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du

Updated on:January 07,2024

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Updated on: July 06,2024

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Updated on:July 06,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on: March 05,2024

Method that rapidly predicts breast cancer survival rates clinically validated

by Ian Mundell,Imperial College LondonFlow diagram of the Digistain protocol. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s10549-023-07229-yDigistain, a company w

Updated on:March 05,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on: March 14,2024

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Updated on:March 14,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on: January 16,2024

Finding new ways to treat diffuse midline gliomas

by Greg Glasgow,CU Anschutz Medical CampusPlanning CTs demonstrating positioning of the mouse on the custom platform and RT fields for the two RT groups, along with the RT schedule for both grou

Updated on:January 16,2024

Breast cancer vaccine safely generates anti-tumor immunity

by Michael McCarthy.,University of WashingtonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI C

Updated on: January 03,2024

Breast cancer vaccine safely generates anti-tumor immunity

by Michael McCarthy.,University of WashingtonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI C

Updated on:January 03,2024

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Updated on: January 02,2024

Efficacy shown for new melanoma therapeutic vaccine

by Physician's Briefing StaffIn a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly

Updated on:January 02,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on: January 30,2024

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Updated on:January 30,2024

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f

Updated on: January 07,2024

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f

Updated on:January 07,2024

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on: August 25,2025

The AI Blind Spot in Oncology: Why Oral Cancer Remains a Diagnostic Challenge

Oral cancer continues to exact a growing toll on global health, with incidence rates rising from 3.26 per 100,000 in 1990 to 5.34 in 2021.

Updated on:August 25,2025